These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

909 related items for PubMed ID: 18646309

  • 1. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S.
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human papillomavirus testing for primary screening of cervical cancer precursors.
    Ratnam S, Franco EL, Ferenczy A.
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
    [Abstract] [Full Text] [Related]

  • 5. Cervical cancer screening in the early post vaccine era.
    Waxman AG.
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Translational approaches to improving cervical screening.
    Baldwin P, Laskey R, Coleman N.
    Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
    [Abstract] [Full Text] [Related]

  • 9. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
    Confortini M, Giorgi Rossi P, Barbarino P, Passarelli AM, Orzella L, Tufi MC.
    J Med Screen; 2010 Mar; 17(2):79-86. PubMed ID: 20660436
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S, Negri G, Sideri M, Santini D, Martinelli G, Venturoli S, Pelusi C, Syrjanen S, Syrjanen K, Pelusi G.
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R, Khawaja NP, Malik N.
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus testing for primary cervical cancer screening.
    Grce M, Davies P.
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC, Beal MW.
    J Midwifery Womens Health; 2004 Sep; 49(1):4-13. PubMed ID: 14710135
    [Abstract] [Full Text] [Related]

  • 18. Cost of screening for cancerous and precancerous lesions of the cervix.
    Méréa E, Le Galès C, Cochand-Priollet B, Cartier I, de Crémoux P, Vacher-Lavenu MC, Vielh P, Coste J.
    Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
    Cecchini G, Paganini G, D'Amico M, Cannone M, Bertuletti C, Barberis MC.
    Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.